How much is Encoded Therapeutics worth in 2026?

Encoded Therapeutics has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Encoded Therapeutics raised?

Encoded Therapeutics has raised N/A in total funding across 1 funding rounds.

Encoded Therapeutics

Drug Discovery

Encoded Therapeutics valuation and funding history | Last updated: April 18, 2017 | 1 funding rounds

Current Valuation

N/A

As of April 18, 2017

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Apr 2017

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 18, 2017	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Encoded Therapeutics is currently valued at N/A as of April 18, 2017.

Track Encoded Therapeutics Valuation Updates

Get notified when Encoded Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Encoded Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Encoded Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Encoded Therapeutics Worth in 2026?

Encoded Therapeutics is a leading private company in the Drug Discovery sector. Track Encoded Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Encoded Therapeutics Valuation is Determined

Private company valuations like Encoded Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.